Become A Sponsor
Biotech | Kudrna's Stock Market Talk

Posts Tagged ‘Biotech’

avatar

Biotech: Antares Pharma (AIS) Partnership With Teva

You may have noticed the news stories this morning announcing a patent litigation settlement between Mylan/Pfizer (the makers of the branded Epi-Pen epinephrine product) and Intelliject/Sanofi.  (more…)

More on this topic (What's this?) Read more on Antares Pharma, Biotechnology at Wikinvest
avatar

EXPstocktrader: The Hepatitis C Gold Rush – Looking For The Right Fit For Idenix’s Drug IDX184

This article is a recap of events currently underway in the Hepatitis C arena compiled with facts from industry experts and articles over the last several weeks about what is currently talking place right now. (more…)

avatar

Biotech: Merck (MRK) C. difficile Program Notes From R&D Day

Ok last of this series of posts of interesting snippets from the recent Merck R&D day. See below for commentary and slides regarding their unique monoclonal antibody program for C. difficile associated diarrhea (CDAD). Important for those who follow Optimer OPTR and Cubist CBST, among others. I am working on a more complete analysis of the prospects for this MK3415A program, which is currently in phase 3 development. (more…)
avatar

Biotech: Biomarkers And The Future Of Cancer Drug Development

was emphasizing the importance of cancer biomarkers in the R&D day presentation. See the chart below for the pipeline programs, indication, and biomarker strategy. (more…)

avatar

Weekly Homework: Can Bonds Break The Trend? (w/ Economic Calendar & Stock Radar)

The trend continues and bonds sold off this week helping fuel more upside gains in the stock market. As noted in last week’s homework, a weekly trend has developed in bonds as they strengthen one week only to sell off the next week. That would mean if the trend continues, bonds will strengthen once again this week which could limit upside gains or even create a stock market pullback. (more…)

More on this topic (What's this?)
The Secrets of Bond Investing
An Important Sell Signal
Read more on Bond Investing at Wikinvest
avatar

Biotech: Merck R&D Presentation RE: BACE Alzheimer’s Disease Program

Full report coming soon, but see below for some reference material from the recent Merck R&D day presentation regarding their beta-secretase (BACE) program for Alzheimer’s Disease. They don’t say much about the details, but repeated their description of the program as “potentially transformative” at their recent JP Morgan webcast. (more…)
More on this topic (What's this?)
Understanding the Beta Coefficient
5 High Beta Stocks That Could Rally In 2012
5 Stocks That Just Turned Very Bullish
Read more on Merck, Beta at Wikinvest
avatar

Biotech: Merck Day Slides And Notes RE: Biosimilars

See below for some snippets and slides from Merck R&D day about their biosimilars programs (saved before more recent headlines about new Enbrel patent, AMGN-WPI, and BAX-MNTA collaborations). Perhaps the slide and commentary collection will be useful to you. (more…)
avatar

Weekly Homework: When Will Bonds Unravel? (w/ Economic Calendar & Stock Radar)

Our first full week of the new year and even with some red flags, we ended the week slightly higher.  The crisis has shown its face once again and Friday saw a list of credit downgrades dominate the headlines all day long.  Even as I write this days later, you can find articles galore discussing that topic.  The situation is not pretty, but these downgrades should not come as a shock.  (more…)

More on this topic (What's this?)
The Secrets of Bond Investing
An Important Sell Signal
Read more on Bond Investing at Wikinvest
avatar

Potential Trades w/ Charts: Markets Refuse To Pullback

Referencing the weekly stock radar, I am highlighting a few of the below for . We started out the day flat but when treasuries started to run higher, stocks started to pullback for much of the day.  This created some consolidation as heading into the afternoon, treasuries started to sell-off slightly and many stocks had a decent close, especially for biotechnology and small-cap oil.  The markets continue to show resiliency and intraday weakness is limited as dip buyers emerge.  Referencing last night’s article, if  can make it above $19 tomorrow, we will have good reason to think we can surge higher past $19.50 giving equities more fuel to rise as well. (more…)

avatar

BreakoutTrader: Rating Cramer’s Game Plan Stocks: Week of 1/9/2012

Introduction

, the CNBC host of Mad Money show, publishes his
game plan on each Friday for the following week in which he
comments on the stocks he will be watching. (more…)

Sponsor Ad

>